Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Receives Average Rating of “Hold” from Brokerages

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) has been assigned an average recommendation of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company.

A number of analysts have issued reports on the company. The Goldman Sachs Group lowered Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Sanford C. Bernstein cut Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th.

Carl Zeiss Meditec Stock Up 0.0%

Shares of OTCMKTS:CZMWY opened at $31.84 on Friday. The stock’s 50-day moving average is $40.63 and its 200-day moving average is $47.24. Carl Zeiss Meditec has a 52-week low of $29.92 and a 52-week high of $76.28.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.